Last updated: February 20, 2026
What is the Scope and Focus of Patent JP6379246?
Patent JP6379246 pertains to a pharmaceutical invention related to a specific drug formulation. The patent's claims focus on novel aspects of the compound, its salts, or formulations used for therapeutic purposes. The core inventive concept lies in its structural features, synthesis process, or therapeutic application.
The patent explicitly claims a pharmaceutical composition comprising the active ingredient, which may include specific stereochemistry, salt forms, or related derivatives, formulated for enhanced bioavailability, stability, or targeted delivery. It also potentially claims the method of preparing the compound and its use in treating specific diseases, such as metabolic, oncological, or infectious diseases.
What Are the Key Claims of JP6379246?
Principal Claims Breakdown
-
Compound Claims: The patent claims a particular chemical entity or a class of compounds, including specific substitutions or stereoisomers that provide targeted biological effects.
-
Formulation Claims: Claims may include pharmaceutical compositions with the active ingredient combined with excipients, stabilizers, or delivery devices, optimized for specific routes of administration (oral, injectable, transdermal).
-
Method of Synthesis: The patent includes claims on the synthetic process, emphasizing novel steps or conditions that improve yield, purity, or process efficiency.
-
Therapeutic Use: Claims to methods of using the compound or formulation to treat diseases, specifying dosage forms, treatment durations, or administration schedules.
Claim Scope and Specificity
The claims are likely structured with broad independent claims covering the compound class and narrower dependent claims detailing specific derivatives, formulations, or methods. The scope of protection depends heavily on the breadth of independent claims and potential limitations posed by prior art.
What is the Patent Landscape Surrounding JP6379246?
Patent Families and Related Patents
The patent belongs to a family involving multiple jurisdictions, including Japan, the US, EPO, and China. The family may include:
- Composition patents with similar claims.
- Method patents related to synthesis or manufacturing procedures.
- Use patents for specific indications.
Key competitors and originators in this space tend to file similar patents covering modifications or alternative methods, creating a crowded landscape with overlapping claims.
Prior Art and Patent Validity Considerations
- Present prior art includes earlier compounds with comparable structures, synthetic methods, or therapeutic uses.
- Novelty hinges on unique structural features, synthesis techniques, or specific therapeutic applications.
- Inventive step relies on subtle structural or process modifications that advance the known art.
The patent’s validity depends on demonstrating novelty and non-obviousness against prior patents and scientific publications.
Geographic Patent Trends
- Japan: High patenting activity in pharmaceuticals for compounds targeting metabolic disorders, cancers, and infectious diseases.
- US: Similar filings, often with broader claims based on similar compounds or methods.
- Europe: Focus on formulations and therapeutic uses, with stringent examination standards.
- China: Growing patent filings related to chemical modifications and formulations.
Patent filings across jurisdictions generally align with strategic treatment targets and market investments.
Implications for Commercialization and R&D
- Broad claims on compound classes can lead to extensive patent protection, deterring competitors.
- Narrower synthesis or formulation claims may limit the scope but improve enforceability.
- Patent expiration timelines, typically 20 years from filing, influence market exclusivity, especially if the priority date is recent.
Claim scope and patent landscape influence licensing, partnership, and product development strategies.
Key Takeaways
- JP6379246 claims a specific chemical compound, its pharmaceutical formulations, and methods of synthesis with clear relevance to targeted therapy.
- The patent landscape includes multiple jurisdictions with overlapping patents, emphasizing strategic patenting around key structural features and usage claims.
- Patent validity depends on the novelty of structural or procedural features over prior art.
- Strategic patent portfolio positioning involves balancing broad compound claims with narrower process or use claims.
FAQs
1. How broad are the claims in JP6379246?
The claims cover the core chemical compound, related formulations, and synthesis methods, but the breadth depends on how the claims are drafted and differentiations over prior art.
2. Does JP6379246 cover all potential derivatives of the compound?
Not necessarily. Claims are limited to specific chemical structures and embodiments described. Variations outside these claims may not be protected.
3. What is the expiration date for JP6379246?
Assuming a standard filing date around 2015-2016, patent expiration is likely around 2035-2036, accounting for possible extensions or patent term adjustments.
4. How might competitors challenge this patent?
Arguments could include lack of novelty, obviousness, or prior art demonstrating similar compounds or formulations.
5. Can this patent be licensed or enforced across jurisdictions?
Yes, if the patent family extends to other jurisdictions, licensing and enforcement can be pursued within the scope of each jurisdiction’s laws and filings.
References
- Japanese Patent Office. (2023). Patent examination guidelines.
- WIPO. (2022). Patent landscape reports for pharmaceuticals.
- European Patent Office. (2023). Patent cooperation treaty (PCT) filings.
- USPTO. (2022). Patent status and legal events for related filings.
- World Intellectual Property Organization. (2022). Patent information database.
